Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajer Yousef Almudaiheem

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|October 20, 2022
Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A retrospective analysis of claims databaseAhmed Hamden Al-Jedai, Hajer Yousef Almudaiheem, Dema Abdulrahman Alissa, et al.
Plos One|July 26, 2022
Restriction on antimicrobial dispensing without prescription on a national level: Impact on the overall antimicrobial utilization in the community pharmacies in Saudi ArabiaAhmed Hamdan Al-Jedai, Yasser Almogbel, Khalid Eljaaly, et al.
Dermatology and Therapy|August 9, 2023
Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)Mohammad Ibrahim Ahmad Fatani, Abdullah Alkhalifah, Amaal Farhan Salman Alruwaili, et al.
Journal of Medical Economics|December 28, 2022
Informing a cost-effectiveness threshold for Saudi ArabiaAhmed Hamdan Al-Jedai, James Lomas, Hajer Yousef Almudaiheem, et al.
Saudi Medical Journal|December 16, 2025
Real-world evidence of Nusinersen treatment for patients with spinal muscular atrophy in the Kingdom of Saudi Arabia: Initial insights from the Saudi national spinal muscular atrophy programAhmed H Al-Jedai, Hajer Yousef Almudaiheem, Tareef Y Alaama, et al.
Clinical Rheumatology|January 13, 2024
The Saudi consensus recommendations for the management of psoriatic arthritis (2023)Ibrahim Abdulrazag Al-Homood, Nayef Al Ghanim, Mohammad Ibrahim Ahmad Fatani, et al.
Advances in Therapy|January 19, 2024
Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal StudyMohammed AlHarbi, Abdullah Othman, Ahmed Ali Nahari, et al.
The Journal of Dermatological Treatment|July 21, 2021
Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020)Mohammad Ibrahim Ahmad Fatani, Issam Ribhi Ahmad Hamadah, Mohammed Abdulaziz Alajlan, et al.
BMC Rheumatology|November 22, 2022
Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelinesMohammed A Omair, Hanan Al Rayes, Joanne Khabsa, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|October 20, 2022
Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A retrospective analysis of claims databaseAhmed Hamden Al-Jedai, Hajer Yousef Almudaiheem, Dema Abdulrahman Alissa, et al.
Plos One|July 26, 2022
Restriction on antimicrobial dispensing without prescription on a national level: Impact on the overall antimicrobial utilization in the community pharmacies in Saudi ArabiaAhmed Hamdan Al-Jedai, Yasser Almogbel, Khalid Eljaaly, et al.
Dermatology and Therapy|August 9, 2023
Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)Mohammad Ibrahim Ahmad Fatani, Abdullah Alkhalifah, Amaal Farhan Salman Alruwaili, et al.
Journal of Medical Economics|December 28, 2022
Informing a cost-effectiveness threshold for Saudi ArabiaAhmed Hamdan Al-Jedai, James Lomas, Hajer Yousef Almudaiheem, et al.
Saudi Medical Journal|December 16, 2025
Real-world evidence of Nusinersen treatment for patients with spinal muscular atrophy in the Kingdom of Saudi Arabia: Initial insights from the Saudi national spinal muscular atrophy programAhmed H Al-Jedai, Hajer Yousef Almudaiheem, Tareef Y Alaama, et al.
Clinical Rheumatology|January 13, 2024
The Saudi consensus recommendations for the management of psoriatic arthritis (2023)Ibrahim Abdulrazag Al-Homood, Nayef Al Ghanim, Mohammad Ibrahim Ahmad Fatani, et al.
Advances in Therapy|January 19, 2024
Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal StudyMohammed AlHarbi, Abdullah Othman, Ahmed Ali Nahari, et al.
The Journal of Dermatological Treatment|July 21, 2021
Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020)Mohammad Ibrahim Ahmad Fatani, Issam Ribhi Ahmad Hamadah, Mohammed Abdulaziz Alajlan, et al.
BMC Rheumatology|November 22, 2022
Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelinesMohammed A Omair, Hanan Al Rayes, Joanne Khabsa, et al.
Pageof 1